Skip to main content

Advertisement

Figure 3 | Molecular Cancer

Figure 3

From: In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer

Figure 3

Top – mRNA expression as quantified using Taqman RT-PCR following RNAi for PPARα using RNAi concentration shown. Middle – Cell growth following RNAi and treatment with fenofibrate (FN) and ATRA (RA) for 48 hours. Cell numbers were corrected to adjust for the reduced cell growth following PPARα RNAi compared to control RNAi. Bottom – Apoptosis measured by FACS analysis using Annexin-FITC staining following RNAi and treatment with fenofibrate and retinoic acid for 3 hours.

Back to article page